Canada Authorizes First Bivalent Booster Shot for 5- to 11-Year-Olds

OTTAWA (Reuters) – Canada on Friday authorized Pfizer-BioNTech’s bivalent COVID-19 vaccine booster for children 5 to 11 years of age, according to statement from Health Canada.

Pfizer-BioNTech’s shots are designed to target the BA.4/BA.5 variants of Omicron as well as the original coronavirus variant, and is the first bivalent booster authorized in Canada for 5- to 11-years age group, Health Canada said.

(Reporting by Ismail Shakil in Ottawa)

Source: Read Full Article